The same macro, two opposite reports

Pegasystems, the Cambridge, Massachusetts vendor of workflow and customer-engagement software sold to banks, insurers, healthcare payers and governments, told investors on 22 July that its customers had stopped signing. Annual contract value (ACV) — the only clean growth measure at a company whose reported revenue lurches on upfront license accounting — reached $1.62bn, short of the $1.658bn expected. That is 7% growth, against 12% the prior quarter and 17% two quarters before. Founder and chief executive Alan Trefler called it a "max confusion moment", with enterprises whipsawing between maximizing AI spend and controlling it. Management had already back-loaded two-thirds of the year's net-new ACV into the second half; it then said the first half "significantly underachieved" and that recovery "will be very difficult". Citizens cut the stock to Market Perform, and a Sell downgrade followed on 13 August citing execution and competition.

Two weeks later Appian, the McLean, Virginia low-code vendor whose platform generates the forms, workflows and data models that would otherwise be hand-coded, reported the same environment with the opposite result. Cloud subscription revenue rose 23% to $131.7m, and net expansion inside existing cloud accounts held at 115%. Adjusted EBITDA of $16.2m beat the company's own $5-8m guide. Full-year revenue guidance went to $845-853m — above where analysts sat. Management said it saw no lengthening of deal cycles and pulled 2027 hiring forward into this year.

Whether AI eats the workflow tool

This is the rung of enterprise software with the most direct exposure to agents that write a process rather than execute a designed one. So far the evidence at Appian runs the other way: 85% of second-quarter new logos bought AI-enabled tiers, and it cited a health insurer expecting more than $10m of savings over three years from automated medical-records processing. Its pitch is to be the deterministic layer underneath the models — governance, data access, an auditable process.

Pegasystems is making a nearly identical argument and getting a worse hearing. It shipped Infinity 26 in July, extended its Blueprint design tool across the full build-and-operate lifecycle, and exposed the platform so outside agents can invoke Pega workflows — priced per case rather than per token, explicitly to spare customers runaway token costs. Pega Cloud ACV grew 22% in constant currency and is now 57% of total, but that decelerated from 27%, and the mix shift keeps pressuring legacy license and maintenance lines on the way to a targeted 75%.

What each price already pays for

Appian's re-rating has been fast: price-to-gross-profit stood at 3.07x in early May and 3.63x in late July, and is 4.62x on forward gross profit now. That is roughly 38x forward earnings on consensus of $0.99, paid against a curve consensus expects to slow to 10.7% revenue growth in 2027. Gross margin compressed to 71.2% from 74.3% a year earlier on AI cost mix, and the operating line swung to -2.7% with an $11.8m net loss.

Pegasystems is priced as the broken one. It trades at 13.8x forward earnings against 17.8x trailing, and 3.90x forward gross profit against the 4.72x it carried in May — a month of gains has not restored its own three-month multiple. The cash is real: $288m of first-half free cash flow, full-year guidance of $575m reaffirmed, and $360m spent buying back 9m shares, more than the cash generated. Net income still fell 55.7% to $13.3m.

The month was one stock, and one session

Over the past 22 sessions Appian rose 44% while Pegasystems added 2.8%. Remove each name's two best days and Appian is up 4.7% and Pegasystems is down 15.3%. Pegasystems' single best day, +13.6% on 28 July, was the market-wide rotation out of semiconductors into discounted software, not company news; the same bid lifted ServiceNow and monday.com and returned again on 18 August. Appian's 50-day average crossed above its 200-day in mid-August. Pegasystems' has sat below since 30 January without a break.

One shared overhang remains. The trade-secrets case Appian won — a $2.04bn jury award in 2022 — was reversed, and Virginia's high court upheld that reversal on 8 January 2026, sending it back for a new trial on both liability and damages.

The setup

Where it stands — Appian is executing and richly priced; Pegasystems is cheap with contract-value growth halved and its downtrend unbroken since January. Would confirm — Pegasystems' third-quarter total ACV growth reaccelerating above 7% in constant currency. Would invalidate — Appian's cloud net ARR expansion falling below 110%, or full-year guidance trimmed from $845-853m. Watch next — Pegasystems' third-quarter results, where management itself called the season a "lousy time for turnaround". Valuation — Pegasystems 13.8x forward earnings vs 17.8x trailing; Appian 4.62x forward gross profit vs 3.07x in May.